Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Charter Communications Inc. A

Start price
Target price
Perf. (%)
€521.60
21.08.20
€625.00
04.11.21
13.08%
05.11.21

Could be worthwhile Investment >10% per year
buy
Charter Communications Inc. A

Start price
Target price
Perf. (%)
€521.60
21.08.20
€625.00
04.11.21
13.08%
05.11.21

Could be worthwhile Investment >10% per year
buy
Twitter Inc.

Start price
Target price
Perf. (%)
€32.75
21.08.20
€42.00
14.10.20
22.83%
14.10.20

Could be worthwhile Investment >10% per year
Known brand
Top 10 in its market
buy
NVIDIA Corp.

Start price
Target price
Perf. (%)
€2.54
20.08.20
€3.19
04.11.21
152.74%
05.11.21

buy
NVIDIA Corp.

Start price
Target price
Perf. (%)
€2.54
20.08.20
€3.19
04.11.21
152.74%
05.11.21

buy
NVIDIA Corp.

Start price
Target price
Perf. (%)
€2.54
20.08.20
€3.19
04.11.21
152.74%
05.11.21

buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€95.39
20.08.20
€105.50
04.11.21
1.68%
14.06.21

Future proof or reliable business model
Small cyclical dependencies
Known brand
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€95.39
20.08.20
€105.50
04.11.21
1.68%
14.06.21

Future proof or reliable business model
Small cyclical dependencies
Known brand
Vornado Realty Trust

Start price
Target price
Perf. (%)
€29.20
19.08.20
-
25.10.20
-2.05%
25.10.20

High dividend yield expected
Significant cyclical dependencies
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€55.59
19.08.20
€52.00
24.08.20
0.76%
24.08.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€55.59
19.08.20
€52.00
24.08.20
0.76%
24.08.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€55.59
19.08.20
€52.00
24.08.20
0.76%
24.08.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Restaurant Brands Intl Inc.

Start price
Target price
Perf. (%)
€46.80
19.08.20
€60.00
04.11.21
1.72%
28.01.21

Top 10 in its market
Known brand
buy
Restaurant Brands Intl Inc.

Start price
Target price
Perf. (%)
€46.80
19.08.20
€60.00
04.11.21
1.72%
28.01.21

Top 10 in its market
Known brand
buy
Bayer AG

Start price
Target price
Perf. (%)
€57.13
19.08.20
€70.00
04.11.21
-19.84%
10.11.20

Could be worthwhile Investment >10% per year
Innovative
Very Future proof/growth oriented business model
Known brand
buy
Bayer AG

Start price
Target price
Perf. (%)
€57.13
19.08.20
€70.00
04.11.21
-19.84%
10.11.20

Could be worthwhile Investment >10% per year
Innovative
Very Future proof/growth oriented business model
Known brand
buy
Coca-Cola Co.

Start price
Target price
Perf. (%)
€40.70
19.08.20
€67.00
04.11.21
20.32%
05.11.21

buy
Coca-Cola Co.

Start price
Target price
Perf. (%)
€40.70
19.08.20
€67.00
04.11.21
20.32%
05.11.21

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€58.10
18.08.20
-
04.11.21
-12.10%
11.11.20

Could be worthwhile Investment >10% per year
Capable Management
Innovative
Market Leader or Top 3
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€58.10
18.08.20
-
04.11.21
-12.10%
11.11.20

Could be worthwhile Investment >10% per year
Capable Management
Innovative
Market Leader or Top 3
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€58.10
18.08.20
-
04.11.21
-12.10%
11.11.20

Could be worthwhile Investment >10% per year
Capable Management
Innovative
Market Leader or Top 3
buy
Dollar General Corp.

Start price
Target price
Perf. (%)
€169.04
17.08.20
-
22.10.20
7.64%
22.10.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation
buy
Vonovia SE

Start price
Target price
Perf. (%)
€58.52
17.08.20
€58.00
04.11.21
-8.20%
05.11.21

Could be worthwhile Investment >10% per year
buy
CME Group Inc.

Start price
Target price
Perf. (%)
€147.24
17.08.20
-
18.10.20
-3.74%
18.10.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Low dividend yield expected
buy
CME Group Inc.

Start price
Target price
Perf. (%)
€147.24
17.08.20
-
18.10.20
-3.74%
18.10.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Low dividend yield expected